The studies, published in The BMJ, analysed more than one million hip and knee replacements recorded in the National Joint Registry between 2018 and 2024. They provide the largest real-world evaluation to date of whether robotic assistance translates into better early outcomes for patients.
The findings come at an important point for the NHS. NHS England has set out plans for a major expansion of robotic surgery over the next decade, with the number of robot-assisted procedures across different surgical specialties projected to rise from around 70,000 a year in 2023/24 to 500,000 by 2035. If robotic systems were used for all hip and knee replacements the cost to the NHS would be substantially in excess of £100M annually.
Researchers say the studies underline the need for new surgical technologies to be evaluated against outcomes that matter to patients as they are introduced more widely.
David Murray, Professor of Orthopaedic Surgery at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, and senior author of both studies, said: 'Although robotic surgery can help with some aspects of the operation the important question is whether that ultimately leads to better outcomes for patients. In these studies, we did not find evidence of a reduction in the overall early risk of further surgery.
'That does not mean robotic surgery will have no value for hip and knee replacement, as robotic systems or other technology will improve with time. Furthermore, these are early outcomes and there may be benefits that become apparent with longer follow-up. But as the NHS invests in and expands robotic surgery, it is important that adoption goes hand in hand with rigorous, independent evaluation so that we understand where the technology brings genuine benefit for patients and represents good value for the health service.'
In current robotic-assisted joint replacement, the surgeon remains in control of the operation, using computer and robotic technology to help plan and guide the placement of an implant. Robotic systems are intended to improve the accuracy of implant positioning, but until now there has been limited large-scale evidence about whether these proposed technical advantages translate into fewer repeat operations.
For hip replacement, the researchers found no overall reduction in repeat surgery or mortality associated with robotic-assisted surgery. Robotic hip replacement was associated with a lower risk of further surgery for problems specifically related to poor implant positioning, but this did not translate into an overall reduction in repeat operations.
For knee replacement, there was no difference in the risk of repeat surgery between robotic-assisted and conventional procedures.
The study compares five-year outcomes and longer-term follow-up will be needed to establish whether differences in implant survival emerge over time.
The work was carried out by Mr Hasan Mohammad, now Academic Clinical Lecturer in Trauma and Orthopaedics at Queen Mary University of London. It was begun in Oxford with Professor David Murray and Professor Andrew Judge (now at the University of Bristol) and continued by these researchers when Hasan Mohammad moved to London.
The team used a method known as target trial emulation to analyse large-scale real-world data from the National Joint Registry. The approach aims to make comparisons using observational data to more closely resemble those from a formal clinical trial by balancing groups according to known differences in patient characteristics.
Hasan said: 'This study, which uses novel methodology and represents the largest real-world analysis of its kind worldwide, provides important independent evidence for patients, surgeons and policymakers at a time when robotic hip and knee replacement surgery is being adopted rapidly. New technology should deliver meaningful benefit for patients and represent good value for a publicly funded health service.'
An accompanying editorial in The BMJ, called 'Robot assisted hip and knee arthroplasty: It is high tech, but is it better?', considers the findings in the context of increasing adoption of robotic surgery.
The researchers say continued evaluation will be important as use of the technology grows, particularly to understand longer-term outcomes and identify whether particular groups of patients or particular procedures benefit most.